Respiratory virus co-infection is a risk factor for worse outcomes during Staphylococcus aureus bacteraemia
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
We conducted a retrospective study of adults with Staphylococcus aureus bacteraemia to determine the impact of respiratory virus co-infection. Co-infection, predominantly with SARS-CoV-2, was associated with SAB originating from the respiratory tract (21.1% vs. 5.2%, P =0.002), persistent bacteraemia (13.2% vs . 3.4%, P =0.02) and independently with 30-day mortality (31.6% vs . 18.0%, P =0.04).
